Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
170.34 M EUR
829.51 M EUR
18.30 M
About LABORATORIOS FARMACEUT.
Sector
CEO
Juan López-Belmonte Encina
Headquarters
Madrid
Website
Founded
1946
ISIN
ES0157261019
FIGI
BBG000RL1KS7
Laboratorios Farmaceúticos Rovi SA engages in the research, development, manufacture, and marketing of small molecule and specialty biologic drugs. It operates through the following business segments: Manufacturing, Marketing, and Other. The Manufacturing segment obtains its income from service contracts that relate to the finalization of the pharmaceutical product production process for external entities and the manufacture of products to be subsequently marketed by other group companies. The Marketing segment purchases and sells pharmaceutical products. The Other segment includes other services, research, and development activities that are not significant for the group. The company was founded on December 21, 1946 and is headquartered in Madrid, Spain.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on BER exchange LABORATORIOS FARMACEUT. stocks are traded under the ticker 41L.
We've gathered analysts' opinions on LABORATORIOS FARMACEUT. future price: according to them, 41L price has a max estimate of 99.00 EUR and a min estimate of 83.50 EUR. Watch 41L chart and read a more detailed LABORATORIOS FARMACEUT. stock forecast: see what analysts think of LABORATORIOS FARMACEUT. and suggest that you do with its stocks.
Yes, you can track LABORATORIOS FARMACEUT. financials in yearly and quarterly reports right on TradingView.
LABORATORIOS FARMACEUT. is going to release the next earnings report on Mar 4, 2025. Keep track of upcoming events with our Earnings Calendar.
41L net income for the last quarter is 69.15 M EUR, while the quarter before that showed 51.51 M EUR of net income which accounts for 34.25% change. Track more LABORATORIOS FARMACEUT. financial stats to get the full picture.
Yes, 41L dividends are paid annually. The last dividend per share was 0.89 EUR. As of today, Dividend Yield (TTM)% is 1.39%. Tracking LABORATORIOS FARMACEUT. dividends might help you take more informed decisions.
LABORATORIOS FARMACEUT. dividend yield was 1.49% in 2023, and payout ratio reached 27.20%. The year before the numbers were 2.91% and 28.06% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 4, 2024, the company has 2.11 K employees. See our rating of the largest employees — is LABORATORIOS FARMACEUT. on this list?
Like other stocks, 41L shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LABORATORIOS FARMACEUT. stock right from TradingView charts — choose your broker and connect to your account.